Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges

被引:2
|
作者
Le-Petross, Huong T. [1 ,2 ]
Balema, Wintana [2 ,3 ,4 ]
Woodward, Wendy A. [2 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Univ Texas MD Anderson Canc Ctr, Dept Breast Radiol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Morgan Welch IBC Clin & Res Program, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Inflammatory breast cancer (IBC); peau d'orange; erythema; skin thickening; redness; breast swelling; breast cancer; T4D; CARCINOMA; EPIDEMIOLOGY; SURVEILLANCE; PROGRAM; MRI;
D O I
10.21037/cco-21-116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of this narrative review is to summarize the contributors to misdiagnosis or delayed diagnosis of inflammatory breast cancer (IBC) and strategies for expedient diagnosis. Background: Patients with IBC often report the disease as initially being misdiagnosed, most commonly as mastitis. Methods: We reviewed the literature on this challenging diagnosis by using sequential PubMed search criteria including IBC breast symptoms, IBC diagnosis, and IBC imaging modalities to augment the authors' knowledge of IBC. Other references were added from the manuscripts identified in the PubMed searches and from manuscript reviewers. Conclusions: Several factors contribute to the delayed diagnosis of IBC. One important factor is that IBC is uncommon, and many generalists may not be aware of it in the differential diagnosis of breast skin symptoms. Several features of IBC contribute to the low sensitivity of mammography for its detection, and so the diagnosis is based on clinical factors and is thereby subjective. The presentation can be highly varied; classic textbook images that do not capture the range of presenting signs and symptoms across skin tones may contribute to missed diagnoses in patients with atypical presentations. In fact, the staging system of the American Joint Committee on Cancer, which requires erythema of the breast skin for diagnosis, may exclude patients with obvious global breast skin findings that are not explicitly red. We present an adapted algorithm for working up the undiagnosed inflammatory breast to ensure the timely and accurate diagnosis of IBC. We assert that frank, non-erythematous global skin signs in an enlarged breast with diffuse breast malignancy are sufficient to diagnose IBC if the timing of these signs and findings on biopsy are consistent. We further provide images of atypical IBC identified by global breast skin signs, including peau d'orange, consistent with IBC in the absence of frank erythema.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Endocrine resistance in breast cancer - how to overcome it?
    不详
    [J]. EJC SUPPLEMENTS, 2004, 2 (09): : 41 - 42
  • [3] Challenges: How to overcome them
    Autrup, H.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S22 - S22
  • [4] Imaging Challenges in Diagnosing Triple-Negative Breast Cancer
    Schopp, Jennifer G.
    Polat, Dogan S.
    Arjmandi, Firouzeh
    Hayes, Jody C.
    Ahn, Richard W.
    Sullivan, Kirbi
    Sahoo, Sunati
    Porembka, Jessica H.
    [J]. RADIOGRAPHICS, 2023, 43 (10)
  • [5] Secondary malignancies in survivors of breast cancer: How to overcome the risk
    Shilkrut, Mark
    Belkacemi, Yazid
    Kuten, Abraham
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E86 - E89
  • [6] Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
    Le, Lynne
    Schairer, Catherine
    Hablas, Ahmed
    Ramadan, Mohamed
    Merajver, Sofia
    Seifeldein, Ibrahim
    Soliman, Amr
    [J]. CANCER RESEARCH, 2015, 75
  • [7] Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
    Le L.
    Schairer C.
    Hablas A.
    Meza J.
    Watanabe-Galloway S.
    Ramadan M.
    Merajver S.D.
    Seifeldin I.A.
    Soliman A.S.
    [J]. BMC Research Notes, 10 (1)
  • [8] Utilizing liposomes and lipid nanoparticles to overcome challenges in breast cancer treatment
    Varshochian, Reyhaneh
    Hosseinzadeh, Hosniyeh
    Gandomi, Narges
    Tavassolian, Faranak
    Atyabi, Fatemeh
    Dinarvand, Rassoul
    [J]. CLINICAL LIPIDOLOGY, 2014, 9 (05) : 571 - 585
  • [9] "Why and What" for the optimal management of inflammatory breast cancer
    Ueno, Naoto T.
    Alexander, Angela
    [J]. CHINESE CLINICAL ONCOLOGY, 2021, 10 (06)
  • [10] Breast Cancer Screening: Why, When, and How Many?
    Gemignani, Mary L.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (01): : 125 - 132